Vertex reported solid fourth-quarter numbers throughout its business. While the company's earnings per share came in slightly shy of expectations, top-line revenue growth was a significant beat.
From Amazon Bedrock and Google Vertex AI to Salesforce Einstein GPT and OpenAI’s GPT-4, CRN breaks down the 10 coolest AI tools and GenAI products of 2023. Artificial intelligence tools flooded ...
By integrating GenAI and Google Cloud’s Vertex AI platform, Deimos is helping Salus automate critical security processes.
Google (GOOG) expands its partnership with Reddit (RDDT) to enhance AI capabilities and improve search relevance with Vertex AI and API integration.
Counterpart Health, MEDITECH, and Suki are using Vertex AI Search for healthcare to improve clinicians' access to information and gain a more comprehensive view on patient health SUNNYVALE, Calif.
Vertex provided 2025 revenue guidance of $11.75 billion to $12 billion, reflecting 8% growth at the midpoint. Growth is expected from U.S. launches of ALYFTREK and JOURNAVX, along with the ...
Hosted on MSN29d
Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis PipelineVertex Pharmaceuticals dominates the market for cystic fibrosis drugs, but Sionna Therapeutics contends the pharma company’s products still have efficacy and safety limitations. Sionna has ...
Vertex Pharmaceuticals (Nasdaq: VRTX) specialises in treatments for rare diseases. It has eight approved medicines on the market. Seven of these are medicines for various types of cystic fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results